Received by email:

File: Abattis_NR_ Stock option July222014.docx

ABATTIS ANNOUNCES GRANT OF STOCK OPTIONS

Vancouver, BC - July 22, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF) (CSE: ATT), the
---> Company is pleased to announce that, in compliance with the Company's option plan, the Company has granted 2,438,100 
--->incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into
---> a common share of Abattis at $0.64 per share for a period of five years.
About Abattis Bioceuticals Corp.
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, l
--->icensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to m
--->edicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana 
--->legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and pa
--->rtnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketi
--->ng support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual p
--->roperty for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to 
--->the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.aba
--->ttis.com. 
ON BEHALF OF THE BOARD
"Mike Withrow"
Michael Withrow, President & CEO
For further information, contact the Company's CEO, Michael Withrow at (778) 896-6536 or at news@abattis.com.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY 
--->FOR THE ADEQUACY ORACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION This press release contains forward-looking statements. The use of any of the words "antic
--->ipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are in
--->tended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on 
--->which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-look
--->ing statements because the Company can give no assurance that they will prove to be correct. Since forward-looking sta
--->tements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Thes
--->e statements speak only as of the date of this press release. Actual results could differ materially from those curren
--->tly anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Disc
--->ussion and Analysis under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertak
--->e to update this information at any particular time.